All Updates

All Updates

icon
Filter
Partnerships
Caris Life Sciences partners with Juniper Biologics to provide tumor profiling services to Middle East and Africa
Precision Medicine
Jun 24, 2024
This week:
Partnerships
Sheeva.AI and P97 Networks partner for in-car payment solutions at fuel stations
Auto Tech
Today
Product updates
Food Cycle Science launches 'Food Cycler Eco 3,' a household food waste processing bin
Food Waste
Yesterday
Partnerships
Von Holzhausen and Herman Miller partner to launch plant-based leather Eames Chair
Bio-based Materials
Yesterday
Partnerships
Volvo Cars partners with Beijing Shougang and Zhejiang Yiyun for automotive steel recycling
Waste Recovery & Management Tech
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Carbon Capture, Utilization & Storage (CCUS)
Yesterday
Funding
LanzaJet receives strategic investment from Airbus
Alternative Energy
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
Pet Care Tech
Yesterday
Partnerships
Odie Pet Insurance partners with Insuritas to offer pet coverage through financial institutions
InsurTech: Personal Lines
Yesterday
M&A
Applied Systems acquires Planck for undisclosed sum to expand AI capabilities
InsurTech: Infrastructure
Yesterday
Product updates
Monzo launches pension consolidation product
Neobanks
Yesterday
Precision Medicine

Precision Medicine

Jun 24, 2024

Caris Life Sciences partners with Juniper Biologics to provide tumor profiling services to Middle East and Africa

Partnerships

  • Caris Life Sciences has entered a commercial distribution agreement with Juniper Biologics for its tumor profiling services in the Middle East and Africa. This expansion follows the partnership with Caris to expand the same services to Southeast Asia (SEA) regions.

  • This exclusive partnership with Caris Life Sciences will allow Juniper Biologics to distribute this service to healthcare professionals in the Middle East and Africa. The service aims to enable more informed decisions regarding patient care. It enables oncologists to recommend highly personalized and targeted treatments, which expands care options and improves the quality of life for cancer patients.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.